Drug recall: MidNite Sleep Health melatonin tablets, cGMP deviations
Ultra Seal Corporation is voluntarily recalling MidNite Sleep Health melatonin tablets nationwide due to current good manufacturing practice (cGMP) deviations. Approximately 2.2 million bottles are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily by the firm for cGMP deviations. No reported illness, injury, or hospitalization is stated in the source text. Absent specific evidence of serious harm or a high-risk pathogen, this falls under a precautionary recall with manufacturing process concerns.
Plain-English summary
Ultra Seal Corporation is recalling MidNite Sleep Health melatonin tablets (1.5 mg) in 30-count bottles due to current good manufacturing practice (cGMP) deviations. The affected product was distributed nationwide across the United States.
Approximately 2,189,232 bottles are subject to this recall. Specific lot numbers include 18L124, 18L125, 18L126 (expiration date 02/2022); 19C037, 19C038, 19C039, 19C040 (expiration date 03/2022); 19D029, 19D030 (expiration date 04/2022); 19D031 (expiration date 06/2022); and 19G047 (expiration date 07/2022).
This is a voluntary recall initiated by the manufacturer. Consumers who have purchased affected product should stop use and contact Ultra Seal Corporation or the distributor, Mylan Consumer Healthcare, Inc., with questions.
The recalled product
- Product
- MidNite Sleep Health (melatonin 1.5 mg) tablets, 30-count bottles, Distributed by: Mylan Consumer Healthcare, Inc. Morgantown, WV 26505 USA
- Manufacturer
- Ultra Seal Corporation
- Category
- Drug — Dietary Supplement
- Affected units
- 2,189,232
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Lot #: 18L124
- 18L125
- 18L126
- Exp. Date 02/2022
- 19C037
- 19C038
- 19C039
- 19C040
- Exp. Date 03/2022
- 19D029
- 19D030
- Exp. Date 04/2022
- 19D031
- Exp. Date 06/2022
- 19G047
- Exp. Date 07/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Terminator decongestant recalled for cGMP deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19